Administration and neuropathology oversight

$133,613P01FY2012CANIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

Paper 39563028 Paper 39138760 Paper 38303726 Paper 37870204 Paper 37824733 Paper 37725979 Paper 37716353 Paper 37194237 Paper 36936071 Paper 36907561 Paper 36870999 Paper 36427266 Paper 36404434 Paper 35849415 Paper 35750648 Paper 35675910 Paper 35666645 Paper 35654978 Paper 35624211 Paper 35624008 Paper 35590035 Paper 35572197 Paper 35417683 Paper 35033904 Paper 35017150 Paper 34890082 Paper 34850166 Paper 34584243 Paper 34446922 Paper 34298912 Paper 34233961 Paper 34183802 Paper 33799709 Paper 33707748 Paper 33687214 Paper 33548389 Paper 33301777 Paper 33282910 Paper 33274611 Paper 33255871 Paper 33240762 Paper 33239433 Paper 33234347 Paper 33103361 Paper 33103128 Paper 33051308 Paper 32881418 Paper 32815324 Paper 32815321 Paper 32555306 Paper 32519463 Paper 32504554 Paper 32484293 Paper 32457507 Paper 32414213 Paper 32394646 Paper 32383351 Paper 32351054 Paper 32299465 Paper 32203281 Paper 32198420 Paper 32178271 Paper 32075753 Paper 32061674 Paper 32038644 Paper 32019882 Paper 32004403 Paper 31852796 Paper 31839905 Paper 31628025 Paper 31533034 Paper 31413142 Paper 31242427 Paper 31092696 Paper 30951671 Paper 30951667 Paper 30949309 Paper 30943406 Paper 30916923 Paper 30889795 Paper 30842671 Paper 30759398 Paper 30637094 Paper 30561734 Paper 30456354 Paper 30445298 Paper 30288631 Paper 30279232 Paper 30257000 Paper 30254196 Paper 30108686 Paper 30082792 Paper 30057404 Paper 29985475 Paper 29975720 Paper 29805987 Paper 29696074 Paper 29533646 Paper 29532035 Paper 29388135

Abstract

PROJECT SUMMARY (See instructions): Core A (Administration) will have overall responsibility for: (A). Administration of the Program Project: Experimental Therapeutics and BioMonitoring for Brain Tumors. This will include oversight of science, thematic goals, specimen allocation, personnel, finances and interactions. A project tracking system, interaction log and regular schedule of meetings and reviews insures productive high quality synergies between the three Projects and three Cores. These reviews and interactions include monthly web-based conferences, meetings with the Project and Core Leaders, interaction with Drs. Breakefield and Carter and Messer for thematic evaluation and definitions of end-points of study as well as consultations with the Internal Advisory committee members. Yearly review will be maintained by an External Advisory Board which will be convened. A portion of the Core B Biorepository will reside at the MGH under the aegis of Dr. Hochberg within Core A. (B). Neuropathologic oversight (Stemmer-Rachamimov) of veterinary studies (P1, Core C) and human studies as well as GBM cohorts resides within the Core A. (C). Statistical oversight resides in Core B (Messer) but local (Core A and Project 2,3) assistance is provided by Mrs. Muzikansky (Core A). The latter includes data sharing and pre-publication review. An experienced Scientific Program Manager will support Program Integration and Management by tracking Aims and agenda for monthly conferences.

View original record on NIH RePORTER →